MedTrace Logo

Infertility Treatment

NCT06960551 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2025-05-07

No results posted yet for this study

Summary

The primary objective of this project is to increase the treatment compliance and success of infertile couples based on the Knowledge-Motivation-Behavioral Skills model.

To develop a mobile web application and evaluate its effectiveness with scientific methods.

The secondary aim was to evaluate the effect of using a mobile application on Infertility Affect Status, Self-Efficacy, Infertility Adjustment and State-Trait Anxiety.

effect of the impact of the study.

Conditions

Interventions

OTHER

ınfertility group

Before starting the project, the couples in the experimental group will be informed about the mobile application. The women will use the mobile application weekly for 3 months. 4 times for at least 15 minutes each. To create motivation for use, women in the experimental group will be asked to motivational notification will be sent via the mobile application.

OTHER

control group

Women in the control group will not receive any intervention. After collecting the post-test data in the project, the principle of benefit and equality Taking this into account, women and their husbands participating in the control group will be given the opportunity to use the mobile application free of charge for three months.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Simge Öztürk, Ph.D · Inonu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-20
Primary Completion
2025-09-20
Completion
2025-09-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06960551 on ClinicalTrials.gov